FundingWatcher
Home / Investors / Biotech investors / Biotech investors in Europe

Biotech investors in Europe

Updated 16 Nov 2026

Reset

Venture funds

25 funds, by portfolio companies funded in the last 12 months
#FundSectorsStages LeadsFunded, 12 months
1 Innovate UK
Innovate UK runs funding competitions for businesses and research organizations in emerging technologies, with recent awardees including Ryft and Concretene.
Swindon, United Kingdom
Artificial intelligence, Health care 75% 8
2 HTGF (High-Tech Gruenderfonds)
HTGF invests across various sectors, with recent investments including Rabot Energy and CereGate.
Bonn, Germany
Biotech, Health care Seed, Early stage venture, Late stage venture 28% 5
3 Novo Holdings
Novo Holdings invests in life science companies, with recent companies including Claris Biotherapeutics and Windward Bio.
Hellerup, Denmark
Health care, Biotech Seed, Early stage venture, Late stage venture 36% 4
4 Sofinnova Partners
Sofinnova Partners invests in life sciences from seed to later stage, including T-Therapeutics, Mironid and DISCO Pharmaceuticals.
Paris, France
Biotech, Health care Seed, Early stage venture, Late stage venture 44% 4
5 BlueYard Capital
BlueYard Capital invests in founders with ideas that decentralize markets, with recent investments in Castelion and Cryptio.
Berlin, Germany
Fintech, Biotech Seed, Early stage venture 41% 3
6 Boehringer Ingelheim Venture Fund
Boehringer Ingelheim Venture Fund invests in therapeutic approaches and technologies, with recent investments in smartbax and Brainomix.
Ingelheim Am Rhein, Germany
Biotech, Health care Seed, Early stage venture 47% 3
7 Hummingbird Ventures
Hummingbird Ventures backs outlier founders globally, recently investing in Etched and Lovable.
Brussels, Belgium
Artificial intelligence, Biotech Seed, Early stage venture 28% 3
8 Astanor Ventures
Astanor Ventures backs entrepreneurs regenerating food, the blue ocean economy and agriculture, with recent companies BioFluff and Standing Ovation.
Luxembourg, Belgium
Artificial intelligence, Biotech Seed, Early stage venture, Late stage venture 55% 2
9 Breakthrough Energy Ventures
Breakthrough Energy Ventures targets reliable, affordable power without climate impact, recently backing Type One Energy and Antora Energy.
Paris, France
Energy, Artificial intelligence Seed, Early stage venture, Late stage venture 43% 2
10 Cambridge Innovation Capital
Cambridge Innovation Capital invests in early-stage deep technology and life sciences companies, including T-Therapeutics and Microbiotica.
Cambridge, United Kingdom
Hardware, Artificial intelligence Seed, Early stage venture, Late stage venture 36% 2
11 Dementia Discovery Fund
Dementia Discovery Fund invests exclusively in novel dementia therapeutics, with recent investments in Alchemab Therapeutics and Cerevance.
London, United Kingdom
Biotech, Health care Seed, Early stage venture 42% 2
12 Andera Partners
Andera Partners makes early- and late-stage venture investments, with recent companies including Kainova Therapeutics and Exciva.
Paris, France
Biotech, Health care Early stage venture, Late stage venture 40% 2
13 Exceptional Ventures
Exceptional Ventures focuses on early-stage entrepreneurs and businesses that improve people's lives, and recently backed Sava Technology and Amatera.
London, United Kingdom
Health care, Biotech Seed, Early stage venture 8% 2
14 Forbion Capital Partners
Forbion Capital Partners makes private equity and venture capital investments in buyouts, with recent investments in Kynexis and Beacon Therapeutics.
Naarden, The Netherlands
Biotech, Health care Seed, Early stage venture 49% 2
15 Future Planet Capital
London, United Kingdom
Biotech, Health care Seed, Early stage venture, Late stage venture 3% 2
16 Industrifonden
Industrifonden invests in early-stage technology and life science companies with international potential, including Pixelgen Technologies and Cellevate.
Stockholm, Sweden
Hardware, Biotech Seed, Early stage venture 38% 2
17 Medicxi
Medicxi focuses on life sciences, with recent companies Vaderis Therapeutics and D3 Bio.
London, United Kingdom
Biotech, Health care Seed, Early stage venture 54% 2
18 M Ventures
M Ventures invests in technologies relevant to Merck's core business areas, with recent investments including Neurable and Quintessent.
Amsterdam, The Netherlands
Health care, Biotech Seed, Early stage venture, Late stage venture 37% 2
19 Metaplanet
Metaplanet invests across diversified sectors, with recent companies including bit.bio, xCures and Neurable.
Tallinn, Estonia
Artificial intelligence, Hardware Seed, Early stage venture, Late stage venture 13% 2
20 Nextech Invest
Nextech Invest is a venture capital and private equity firm spanning early to emerging growth stages, with recent companies Circle Pharma and Atavistik Bio.
Zürich, Switzerland
Health care, Biotech Early stage venture, Late stage venture 31% 2
21 Nucleus Capital
Nucleus Capital backs frontier founders, with recent companies Apoha and Biomia.
Berlin, Germany
Biotech, Health care Seed, Early stage venture 32% 2
22 Octopus Ventures
Octopus Ventures supports companies from idea conception to IPO, including Living Optics and Edgify.
London, United Kingdom
Artificial intelligence, Health care Seed, Early stage venture, Late stage venture 54% 2
23 Seventure Partners
Seventure Partners targets Tech/Digital and Life Sciences companies, with recent companies including Microbiotica and Standing Ovation.
Paris, France
Biotech, Health care Seed, Early stage venture, Late stage venture 36% 2
24 SoftBank Vision Fund
SoftBank Vision Fund makes growth capital and social impact investments, with recent companies including WHOOP and Opentrons.
London, United Kingdom
Artificial intelligence, Hardware Seed, Early stage venture, Late stage venture 71% 2
25 XTX Ventures
XTX Ventures invests in startups applying machine learning, recently backing CloudNC and Qureight.
London, United Kingdom
Artificial intelligence, Health care Seed, Early stage venture 22% 2

Table 1. Biotech investors in Europe: venture capital and micro VC funds ranked by biotech companies whose most recent round closed in the last 12 months. Leads is the share of all recorded investments where the fund was lead investor. Source: FundingWatcher. Data as of 16 November 2026.

Biotech investors in Europe
One-time CSV
  • 283 firms, 282 with a website
  • 209 firm email addresses
  • 174 phone numbers
  • CRM-ready CSV, 15 columns
  • Download right after payment
With partner contacts
Compiled to order
  • The full list, plus the people who invest
  • Up to 2 partners per firm, compiled to order
  • Name, job title and LinkedIn where found
  • Verified direct email per person
  • List CSV at once, contacts CSV by mail within 24 hours
Download right after paymentFree 10-row sampleSecure checkout by Stripe

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

investors-sector-biotech-europe.csv283 rows × 15 columns
InvestorTypeLocationEmailPhone
HTGF (High-Tech Gruenderfonds)Venture capital firmBonn, Germany•••@htgf.de+49 22•••
Venture KickStartup incubatorSchlieren, Switzerland•••@venturekick.ch+41 (2•••
Innovate UKEntrepreneurship programSwindon, United Kingdom•••@innovateuk.ukri.org
BpifranceGovernment investment officeMaisons-alfort, France•••@bpifrance.fr+33 (0•••
Forbion Capital PartnersPrivate equity firmNaarden, The Netherlands•••@forbion.com+31 35•••
Novo HoldingsCorporate venture armHellerup, Denmark•••@novo.dk45 35 •••
KfWGovernment investment officeFrankfurt, Germany•••@kfw.de49 69 •••
Sofinnova PartnersVenture capital firmParis, France•••@sofinnovapartners.com+33 (0•••

8 rows of the CSV in 5 of its 15 columns, email and phone masked.

283
Investors
209
With email
174
With phone
189
Active in the last 12 months

Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.

Biotech investors in Europe

30 of 283, most investments first
30 rows
# Investor Type Location Invests in Latest portfolio companies Funded, 12 months Investments Lead Exits Email Phone LinkedIn
1 HTGF (High-Tech Gruenderfonds) Venture capital firm Bonn, Germany Biotech, Health care Rabot Energy, CereGate, syte 17 1,026 290 136 •••@htgf.de +49 22••• In the CSV
2 Venture Kick Startup incubator Schlieren, Switzerland Health care, Biotech UniSieve, Cotierra, Jaipur Robotics 13 1,459 1,342 82 •••@venturekick.ch +41 (2••• In the CSV
3 Innovate UK Entrepreneurship program, Venture capital firm Swindon, United Kingdom Artificial intelligence, Health care Bioliberty, Concretene, Doctoria LTD 27 1,307 976 84 •••@innovateuk.ukri.org In the CSV
4 Bpifrance Government investment office, Investment bank Maisons-alfort, France Artificial intelligence, Hardware WORMSENSING, CarbonFarm Technology, Archeon 19 1,680 454 214 •••@bpifrance.fr +33 (0••• In the CSV
5 European Innovation Council Startup accelerator Brussels, Belgium Hardware, Health care Onego Bio, Quantrol Ox, Cellbox Solutions 17 1,271 921 48 In the CSV
6 Forbion Capital Partners Private equity firm, Venture capital firm Naarden, The Netherlands Biotech, Health care Kynexis, Beacon Therapeutics 2 188 93 54 •••@forbion.com +31 35••• In the CSV
7 Novo Holdings Corporate venture arm, Venture capital firm Hellerup, Denmark Health care, Biotech Claris Biotherapeutics, Windward Bio, Terremoto Biosciences 5 417 150 115 •••@novo.dk 45 35 ••• In the CSV
8 KfW Government investment office, Investment bank Frankfurt, Germany Biotech, Health care CryoTherapeutics, Vectoflow, HelloDuty 198 29 56 •••@kfw.de 49 69 ••• In the CSV
9 Sofinnova Partners Venture capital firm Paris, France Biotech, Health care T-Therapeutics, Mironid, Bon Vivant 5 373 164 76 •••@sofinnovapartners.com +33 (0••• In the CSV
10 EQT Life Sciences Private equity firm Amsterdam, The Netherlands Health care, Biotech FoRx Therapeutics 1 198 74 55 •••@lspvc.com +31 20••• In the CSV
11 Novartis Venture Fund Corporate venture arm, Venture capital firm Basel, Switzerland Health care, Biotech Hepalink, FoRx Therapeutics 2 279 75 77 •••@sosei.com 877 28•••
12 Andera Partners Private equity firm, Venture capital firm Paris, France Biotech, Health care Kainova Therapeutics, Exciva 2 214 85 69 •••@bper.ch 58 818••• In the CSV
13 Bayern Kapital Venture capital firm Landshut, Germany Health care, Artificial intelligence mbiomics, SPiNE, Driveblocks 4 294 41 41 •••@bayernkapital.de +49871••• In the CSV
14 Octopus Ventures Venture capital firm London, United Kingdom Artificial intelligence, Health care Living Optics, Metris Energy, Edgify 9 477 259 73 •••@octopusvnetures.com +44 20••• In the CSV
15 Boehringer Ingelheim Venture Fund Corporate venture arm Ingelheim Am Rhein, Germany Biotech, Health care smartbax, xCures, Tacalyx 4 99 47 12 +49 61•••
16 SFC Capital Angel group, Micro VC fund Northwich, United Kingdom Fintech, Artificial intelligence OSSTEC, Alchera Technologies, Ryft 11 768 267 23 •••@sfccapital.com +44 20••• In the CSV
17 Scottish Enterprise Government investment office Glasgow, United Kingdom Health care, Hardware Bioliberty, Danu Robotics, Mironid 6 392 140 36 •••@scotent.co.uk +03000••• In the CSV
18 Seventure Partners Venture capital firm Paris, France Biotech, Health care Microbiotica, Standing Ovation 2 300 109 75 •••@seventure.fr +33 1-••• In the CSV
19 Kurma Partners Venture capital firm Paris, France Health care, Biotech Tacalyx 1 131 65 18 •••@kurmapartners.com +33184••• In the CSV
20 BioMedPartners Venture capital firm Basel, Switzerland Biotech, Health care TOLREMO therapeutics, Topas Therapeutics, Amal Therapeutics 87 29 22 •••@biomedvc.com +41 61••• In the CSV
21 Future Planet Capital Venture capital firm London, United Kingdom Biotech, Health care Luffy AI, Captura, CellCentric 4 360 12 27 •••@futureplanetcapital.com +44 79••• In the CSV
22 Foundation for Innovation and Technology (FIT) Entrepreneurship program, Government investment office Lausanne, Switzerland Health care, Biotech Adaptyv Biosystems, Carewell, Alithea Genomics 7 345 329 35 •••@fondation-fit.ch +41 21••• In the CSV
23 Verve Ventures Venture capital firm Zug, Switzerland Health care, Artificial intelligence Stake, Nuclera 2 275 37 35 •••@verve.vc In the CSV
24 M Ventures Corporate venture arm, Venture capital firm Amsterdam, The Netherlands Health care, Biotech Polaris Electro-Optics, Quintessent, Future Fertility 5 171 64 17 In the CSV
25 EIC Accelerator Startup accelerator Brussels, Belgium Health care, Biotech Millow.co, D-CRBN, Omegga GmbH 7 543 517 11 In the CSV
26 Innosuisse Government investment office Berne, Switzerland Health care, Biotech UniSieve, KEMARO AG, Seprify 6 232 184 13 •••@innosuisse.ch +41 58••• In the CSV
27 Oxford Science Enterprises Venture capital firm Oxford, United Kingdom Health care, Artificial intelligence Fractile, Quantrol Ox, Salience Labs 7 186 76 15 •••@oxfordsciences.com 01865 ••• In the CSV
28 Eight Roads Ventures Venture capital firm London, United Kingdom Fintech, Health care Kaiko, Sonosemi Medical, Exponent Energy 8 552 236 134 +91 80••• In the CSV
29 Wellington Partners Venture capital firm Munich, Germany Health care, Biotech nyra health 1 252 80 65 •••@wellington-partners.com +44 20••• In the CSV
30 MassChallenge Switzerland Startup accelerator Renens, Switzerland Biotech, Artificial intelligence Treeless, Perovskia, SolidWatts 5 227 219 2 In the CSV

Table 2. Biotech investors in Europe: the first 30 by recorded investments with a website and a location. Email and phone are masked here and complete in the CSV. Source: FundingWatcher. Data as of 16 November 2026. Base: 283.

Most active in the last 12 months

By portfolio companies funded
#InvestorLocation Funded, 12 monthsPortfolioLatest
1 Innovate UK Swindon, United Kingdom 27 163 Bioliberty, Concretene, Doctoria LTD
2 Bpifrance Maisons-alfort, France 19 344 WORMSENSING, CarbonFarm Technology, Archeon
3 European Innovation Council Brussels, Belgium 17 106 Onego Bio, Quantrol Ox, Cellbox Solutions
4 HTGF (High-Tech Gruenderfonds) Bonn, Germany 17 257 Rabot Energy, CereGate, syte
5 Kima Ventures Paris, France 16 325 Topo.io, Rayon, Kelvin
6 Seedcamp London, United Kingdom 15 203 Metaview, Flow Engineering, Rayon
7 Venture Kick Schlieren, Switzerland 13 129 UniSieve, Cotierra, Jaipur Robotics
8 SFC Capital Northwich, United Kingdom 11 185 OSSTEC, Alchera Technologies, Ryft
9 Parkwalk Advisors London, United Kingdom 10 38 OSSTEC, Adsilico, Reclinker
10 Octopus Ventures London, United Kingdom 9 122 Living Optics, Metris Energy, Edgify
11 Picus Capital Munich, Germany 8 69 Reflex, Baselayer, FINN
12 Tiny Supercomputer Investment Company London, United Kingdom 8 64 Zero, Neuphonic, bunch
13 Eight Roads Ventures London, United Kingdom 8 106 Kaiko, Sonosemi Medical, Exponent Energy
14 BlueYard Capital Berlin, Germany 7 25 Zafrens, Castelion, Transcripta Bio
15 Oxford Science Enterprises Oxford, United Kingdom 7 25 Fractile, Quantrol Ox, Salience Labs

Table 3. Biotech investors in Europe: investors in the most companies whose most recent round falls in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Latest rounds in their portfolios

Newest first
10 rows
Company What they do Sector Location Last round Amount Date Total raised Investors on this list Employees Founded
T-Therapeutics T-Therapeutics develops T cell receptor therapies, spun off from the University of Cambridge. Biotech Cambridge, United Kingdom Series B $133.0M 2026-11-05 $224.6M Cambridge Innovation Capital, Sofinnova Partners, University of Cambridge Enterprise 51 to 100 2022
Saidot Saidot provides a platform that helps organisations manage AI risk, compliance, and policy. Artificial intelligence Helsinki, Finland Seed $1.8M 2026-11-05 $1.8M Business Finland 11 to 50 2018
bit.bio Bit.bio provides engineered human cell products and platform services for biomedical research and drug discovery. Biotech Cambridge, United Kingdom Series D $25.0M 2026-11-04 $250.0M Metaplanet 101 to 250 2016
Takenos Takenos offers a digital wallet that lets users receive, send, manage, and spend international money. Fintech Buenos Aires, Argentina Seed $7.0M 2026-11-04 $12.2M Outlier Ventures 11 to 50 2022
OSSTEC OSSTEC develops products for orthopaedic treatment. Hardware London, United Kingdom Series A $8.0M 2026-11-03 $12.7M SFC Capital, Parkwalk Advisors 11 to 50 2021
Zafrens Zafrens provides a throughput platform that links molecular profiles to cell phenotypes for drug discovery. Biotech San Diego, United States Series A $6.0M 2026-11-03 $35.0M BlueYard Capital 11 to 50 2022
Bioliberty Bioliberty develops rehabilitation solutions for degenerative and traumatic conditions as a medtech start-up. Biotech Edinburgh, United Kingdom Series A $3.3M 2026-11-02 $17.4M Innovate UK, Eos, Scottish Enterprise +1 11 to 50 2020
Fractile Fractile develops semiconductor hardware and AI inference systems for large language model processing. Artificial intelligence London, United Kingdom Series C $771.2M 2026-10-29 $1.0B Oxford Science Enterprises, Kindred Capital 101 to 250 2022
Opentrons Unicorn Opentrons develops pipetting robots that automate laboratory experiments in the life sciences. Artificial intelligence Long Island City, United States Series E $40.0M 2026-10-29 $300.2M SoftBank Vision Fund 251 to 500 2014
Reflex Reflex is an open-source Python framework for building and deploying web applications. Software San Francisco, United States Series A $14.0M 2026-10-29 $19.5M Picus Capital 11 to 50 2023

Table 4. Biotech investors in Europe: the 10 most recent rounds of companies they back. Source: FundingWatcher. Data as of 16 November 2026.

Portfolio sectors

Portfolio sectorsCompaniesShare
Software 4,469 73%
Artificial intelligence 1,343 22%
Health care 1,022 17%
Fintech 996 16%
Hardware 964 16%
Biotech 706 12%
Commerce 560 9%
Education 268 4%
Cybersecurity 258 4%
Energy 192 3%

Table 5. Biotech investors in Europe: portfolio companies by sector. Source: FundingWatcher. Data as of 16 November 2026.

Investment stages

Investment stagesInvestorsShare
Early stage investors 251 89%
Seed investors 216 76%
Late stage investors 125 44%
Venture investors 124 44%
Private equity investors 47 17%
Convertible note investors 32 11%
Debt investors 26 9%
Grant makers 26 9%

Table 6. Biotech investors in Europe by stage they invest at. Source: FundingWatcher. Data as of 16 November 2026.

Countries

CountriesInvestorsShare
United Kingdom 68 24%
Germany 60 21%
Switzerland 32 11%
France 23 8%
Belgium 20 7%
The Netherlands 14 5%
Sweden 11 4%
Denmark 8 3%
Finland 8 3%
Spain 7 2%
Italy 7 2%
Luxembourg 6 2%

Table 7. Biotech investors in Europe by headquarters country. Source: FundingWatcher. Data as of 16 November 2026.

Cities

CitiesInvestorsShare
London 40 14%
Paris 18 6%
Munich 14 5%
Berlin 13 5%
Brussels 9 3%
Zürich 9 3%
Stockholm 9 3%
Helsinki 8 3%
Cambridge 6 2%
Amsterdam 5 2%
Basel 5 2%
Geneva 5 2%

Table 8. Biotech investors in Europe by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.

Founded

FoundedInvestorsShare
2020s 19 7%
2010s 108 39%
2000s 74 27%
1990s 38 14%
1980s 13 5%
1970s 5 2%

Table 9. Biotech investors in Europe by founding decade. Source: FundingWatcher. Data as of 16 November 2026.

Method

Sources, fields and exclusions of both files: Method.

Questions

How many biotech investors in Europe are on the list?
283, in the file dated 16 November 2026. 189 of them invested in a company whose most recent round falls in the last 12 months.
How many have an email address?
209 of the 283 carry an email address in the download and 174 a phone number.
What does the CSV contain?
One row per investor, 15 columns: name, types, stages, city, region, country, founded, website, linkedin, investments, funded_last_12m, exits, lead_investments, email, phone.
How much does the list cost?
$29 one-time for all 283 rows, no account. Every investor and every startup, two files, cost $99. With partner contacts, up to 2 per firm compiled to order and mailed within 24 hours, $199.
What arrives after payment?
At once: the CSV with 283 rows, 209 firm email addresses and 174 phone numbers, on the page after payment and by mail. The emails are the address a firm publishes: 158 of the 209 are inboxes such as info@ or contact@. No partner names.
Can I see rows before buying?
The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
How current is the data?
The file is dated 16 November 2026. The download link serves the current file each time it is opened.

Biotech investors in Europe: 283 rows, CSV, $29 one-time.

At once: the CSV with 283 rows, 209 firm email addresses and 174 phone numbers, on the page after payment and by mail.

The emails are the address a firm publishes: 158 of the 209 are inboxes such as info@ or contact@. No partner names.

Columns: name, types, stages, city, region, country, founded, website, linkedin, investments, funded_last_12m, exits, lead_investments, email, phone.

With partner contacts: $199 one-time. List CSV right after payment; up to 2 verified partner emails per firm compiled to order within 24 hours.

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

Biotech investors by city in Europe

Investor types in Europe

Other portfolio sectors in Europe

Biotech investors elsewhere

Biotech startups

Cite: FundingWatcher, 283 biotech investors in Europe, 16 November 2026. https://fundingwatcher.com/investors/sector/biotech/europe/